FLT: measuring tumor cell proliferation in vivo with positron emission tomography and 3'-deoxy-3'-[18F]fluorothymidine.
about
Brain tumorsPositron Emission Tomography in Breast CancerBiomarkers and molecular probes for cell death imaging and targeted therapeuticsPET probes beyond (18)F-FDGPhosphorylation status of thymidine kinase 1 following antiproliferative drug treatment mediates 3'-deoxy-3'-[18F]-fluorothymidine cellular retentionBatch-reactor microfluidic device: first human use of a microfluidically produced PET radiotracer.Integrating Imaging Data into Predictive Biomathematical and Biophysical Models of CancerParametric imaging of ¹⁸F-fluoro-3-deoxy-3-L-fluorothymidine PET data to investigate tumour heterogeneity.The integration of quantitative multi-modality imaging data into mathematical models of tumors.Modeling tumor growth and treatment response based on quantitative imaging dataProof-of-concept study of monitoring cancer drug therapy with cerenkov luminescence imagingAssessment of tracer 99mTc(V)-DMSA uptake as a measure of tumor cell proliferation in vitro.Opportunities and challenges facing biomarker development for personalized head and neck cancer treatment.Review of functional/anatomical imaging in oncology.PET/CT in the staging of the non-small-cell lung cancer.Tumour microenvironment heterogeneity affects the perceived spatial concordance between the intratumoural patterns of cell proliferation and 18F-fluorothymidine uptake18F-fluorothymidine PET imaging in gliomas: an update.A Pilot Study of 18F-FLT PET/CT in Pediatric Lymphoma.The evolving role of nuclear molecular imaging in cancer.Discriminant analysis of ¹⁸F-fluorothymidine kinetic parameters to predict survival in patients with recurrent high-grade glioma.Intermittent dosing of axitinib combined with chemotherapy is supported by (18)FLT-PET in gastrointestinal tumours.Microfluidics for positron emission tomography probe development.Comparative aspects of the proliferation marker thymidine kinase 1 in human and canine tumour diseases.Innovation in cancer imaging.Alternative PET tracers in head and neck cancer. A review.FLT PET-CT in evaluation of treatment response.18F-FLT uptake kinetics in head and neck squamous cell carcinoma: a PET imaging study.Molecular imaging using PET for breast cancer.The histone deacetylase inhibitor PXD101 increases the efficacy of irinotecan in in vitro and in vivo colon cancer models.Preclinical Applications of 3'-Deoxy-3'-[18F]Fluorothymidine in Oncology - A Systematic Review.DW-MRI and (18) F-FLT PET for early assessment of response to radiation therapy associated with hypoxia-driven interventions. Preclinical studies using manipulation of oxygenation and/or dose escalation.A review of the predictive role of functional imaging in patients with mucosal primary head and neck cancer treated with radiation therapy.Identification of imaging biomarkers for the assessment of tumour response to different treatments in a preclinical glioma model.Current clinical status of 18F-FLT PET or PET/CT in digestive and abdominal organ oncology.Whole-body biodistribution of 3'-deoxy-3'-[(18) f]fluorothymidine ((18) FLT) in healthy adult cats.Monitoring of tumor growth and post-irradiation recurrence in a diffuse intrinsic pontine glioma mouse model.18F-FLT and 18F-FDG PET to measure response to radiotherapy combined with celecoxib in two colorectal xenograft models.What are the Best Ways to Reduce the False-positive Rate of 18F-FDG PET/CT in Patients with Breast Cancer?Early assessment of response to induction therapy in acute myeloid leukemia using 18F-FLT PET/CT¹⁸F-FLT PET/CT as an imaging tool for early prediction of pathological response in patients with locally advanced breast cancer treated with neoadjuvant chemotherapy: a pilot study.
P2860
Q24605136-2D8028F4-1EC5-4711-A684-11DB7BB0BD70Q26768486-611D1D45-0B1B-4406-B13F-2FF1A6AA246BQ26866387-185C6E78-B828-4019-95C1-7856395AC0B7Q27004457-6D644AB0-2E4F-4AD1-A850-0E557370EE55Q28540476-0DF2479C-9457-4F6D-99C0-06A03B7B61A8Q30542885-37B2A3B1-1051-4019-A047-22E807AFDC45Q30659261-9D0EF25A-AABD-40CE-8972-1E601AFFBDDBQ30794621-94C99F21-F584-46F1-8422-19F46E75B080Q33550040-95BA6E10-888A-42ED-86BC-41AC96B45072Q33623804-663164B2-F052-4B0F-A69A-8AFB6369AEA5Q34083326-4108BC12-1BFA-4BE9-96EF-BED2CBD4CB05Q34555868-96188BDA-0961-4FAE-9B97-74852A9AE2DFQ35673572-61C4EEF0-D4AF-4DA0-8EC3-6F6963BE6A2BQ35809612-5F7B5DD2-B5F5-4F93-BAE0-178EF771A60AQ35941591-E6441171-BDEE-4C52-BFEB-281F6B9D5632Q36070106-A59551A6-69F3-4476-87D6-B0AD8C338F44Q36404866-E1FD4E32-775B-4BD7-840B-5DA512DBF6DEQ36985532-2AB13573-9A0A-4F5E-806A-D39A2C6E76E5Q37011086-B4D919A7-B34F-475C-8991-574EFD01EA7CQ37323697-53470A42-D1DD-4976-A599-1CF4487D6B0CQ37594384-457007F7-59C0-4904-9FA9-151DAC63BB98Q37774061-102DE571-8CD8-4619-A802-715B5EFA54F6Q37837982-1E416BD6-BC50-4AD6-A73F-B036699CCF68Q38005915-37AF12B9-8F8A-45C3-9ED5-83B30C383394Q38069937-43FAAFFB-F127-4249-AF2C-E4FDF4E1D1A9Q38206772-F4A98322-C012-41D6-8D38-DD2EF7F9D586Q38421316-54B743E5-71B2-43A1-8867-59D74C388047Q38444869-876C12C0-E8E2-4443-84D8-BA76F8267FADQ38480031-00DCDA45-331D-4780-8AF5-E208904C9544Q38775709-DD14F969-D4AE-4770-AAFA-594F9B7B872FQ38780973-65B21668-FACB-48E7-81D8-A4D7F5D8BA08Q38836743-6A8748E3-D648-470C-A3F0-5D9AD6EAD8A5Q38894617-7D7C4FB4-B049-4E4F-A10E-3A2DF272CE63Q38988008-F3206B24-F388-4568-A0E4-D200F2D234A8Q39456555-4744818E-8019-4BDD-BF2B-EE881C532FC0Q39620062-D16B4FC8-C5F5-4727-8535-A25AE0FF53CDQ39804049-C4856410-219C-4C0A-912E-3FD3F5DB5130Q40217923-F47E8D1C-1123-4A29-96FD-28424701EFDDQ41683904-7BC87993-BE43-40E1-90EB-DB5F8A89B3CDQ51009203-701E8D44-10F3-4B85-AD48-344A28CFEEDA
P2860
FLT: measuring tumor cell proliferation in vivo with positron emission tomography and 3'-deoxy-3'-[18F]fluorothymidine.
description
2007 nî lūn-bûn
@nan
2007 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
name
FLT: measuring tumor cell prol ...... deoxy-3'-[18F]fluorothymidine.
@ast
FLT: measuring tumor cell prol ...... deoxy-3'-[18F]fluorothymidine.
@en
FLT: measuring tumor cell prol ...... deoxy-3'-[18F]fluorothymidine.
@nl
type
label
FLT: measuring tumor cell prol ...... deoxy-3'-[18F]fluorothymidine.
@ast
FLT: measuring tumor cell prol ...... deoxy-3'-[18F]fluorothymidine.
@en
FLT: measuring tumor cell prol ...... deoxy-3'-[18F]fluorothymidine.
@nl
prefLabel
FLT: measuring tumor cell prol ...... deoxy-3'-[18F]fluorothymidine.
@ast
FLT: measuring tumor cell prol ...... deoxy-3'-[18F]fluorothymidine.
@en
FLT: measuring tumor cell prol ...... deoxy-3'-[18F]fluorothymidine.
@nl
P2093
P1476
FLT: measuring tumor cell prol ...... deoxy-3'-[18F]fluorothymidine.
@en
P2093
Alexander Salskov
Hubert Vesselle
John Grierson
P304
P356
10.1053/J.SEMNUCLMED.2007.08.001
P577
2007-11-01T00:00:00Z